Late sodium current contributes to diastolic cell Ca2+ accumulation in chronic heart failure

Bers DM (2006) Altered cardiac myocyte Ca regulation in heart failure. Physiology (Bethesda) 21:380–387

Hasenfuss G, Schillinger W, Lehnart SE, Preuss M, Pieske B, Maier LS et al (1999) Relationship between Na+–Ca2+-exchanger protein levels and diastolic function of failing human myocardium. Circulation 99:641–648

Pieske B, Maier LS, Piacentino V 3rd, Weisser J, Hasenfuss G, Houser S (2002) Rate dependence of [Na+]i and contractility in nonfailing and failing human myocardium. Circulation 106:447–453

Hobai IA, Maack C, O’Rourke B (2004) Partial inhibition of sodium/calcium exchange restores cellular calcium handling in canine heart failure. Circ Res 95:292–299

Maltsev VA, Undrovinas A (2008) Late sodium current in failing heart: friend or foe? Prog Biophys Mol Biol 96:421–451

Maltsev VA, Sabbah HN, Higgins RSD, Silverman N, Lesch M, Undrovinas AI (1998) Novel, ultraslow inactivating sodium current in human ventricular cardiomyocytes. Circulation 98:2545–2552

Undrovinas AI, Maltsev VA, Sabbah HN (1999) Repolarization abnormalities in cardiomyocytes of dogs with chronic heart failure: role of sustained inward current. Cell Mol Life Sci 55:494–505

Valdivia CR, Chu WW, Pu J, Foell JD, Haworth RA, Wolff MR et al (2005) Increased late sodium current in myocytes from a canine heart failure model and from failing human heart. J Mol Cell Cardiol 38:475–483

Maltsev VA, Silverman N, Sabbah HN, Undrovinas AI (2007) Chronic heart failure slows late sodium current in human and canine ventricular myocytes: implications for repolarization variability. Eur J Heart Fail 9:219–227

Maltsev VA, Sabbah HN, Tanimura M, Lesch M, Goldstein S, Undrovinas AI (1998) Relationship between action potential, contraction-relaxation pattern, and intracellular Ca2+ transient in cardiomyocytes of dogs with chronic heart failure. Cell Mol Life Sci 54:597–605

Undrovinas AI, Maltsev VA, Kyle JW, Silverman NA, Sabbah HN (2002) Gating of the late Na+ channel in normal and failing human myocardium. J Mol Cell Cardiol 34:1477–1489

Maltsev VA, Undrovinas AI (2006) A multi-modal composition of the late Na+ current in human ventricular cardiomyocytes. Cardiovasc Res 69:116–127

Undrovinas AI, Belardinelli L, Undrovinas NA, Sabbah HN (2006) Ranolazine improves abnormal repolarization and contraction in left ventricular myocytes of dogs with heart failure by inhibiting late sodium current. J Cardiovasc Electrophysiol 17:S169–S177

Maltsev VA, Sabbah HN, Undrovinas AI (2002) Down-regulation of sodium current in chronic heart failure: effects of long-term therapy with carvedilol. Cell Mol Life Sci 59:1561–1568

Zicha S, Maltsev VA, Nattel S, Sabbah HN, Undrovinas AI (2004) Post-transcriptional alterations in the expression of cardiac Na+ channel subunits in chronic heart failure. J Mol Cell Cardiol 37:91–100

Studer R, Reinecke H, Bilger J, Eschenhagen T, Bohm M, Hasenfuss G et al (1994) Gene expression of the cardiac Na+-Ca2+ exchanger in end-stage human heart failure. Circ Res 75:443–453

Flesch M, Schwinger RH, Schiffer F, Frank K, Sudkamp M, Kuhn-Regnier F et al (1996) Evidence for functional relevance of an enhanced expression of the Na(+)-Ca2+ exchanger in failing human myocardium. Circulation 94:992–1002

Pogwizd SM, Schlotthauer K, Li L, Yuan W, Bers DM (2001) Arrhythmogenesis and contractile dysfunction in heart failure: roles of sodium-calcium exchange, inward rectifier potassium current, and residual beta-adrenergic responsiveness. Circ Res 88:1159–1167

Brillantes AM, Allen P, Takahashi T, Izumo S, Marks AR (1992) Differences in cardiac calcium release channel (ryanodine receptor) expression in myocardium from patients with end-stage heart failure caused by ischemic versus dilated cardiomyopathy. Circ Res 71:18–26

Bers DM, Eisner DA, Valdivia HH (2003) Sarcoplasmic reticulum Ca2+ and heart failure: roles of diastolic leak and Ca2+ transport. Circ Res 93:487–490

Belevych A, Kubalova Z, Terentyev D, Hamlin RL, Carnes CA, Gyorke S (2007) Enhanced ryanodine receptor-mediated calcium leak determines reduced sarcoplasmic reticulum calcium content in chronic canine heart failure. Biophys J 93:4083–4092

Hobai IA, O’Rourke B (2001) Decreased sarcoplasmic reticulum calcium content is responsible for defective excitation-contraction coupling in canine heart failure. Circulation 103:1577–1584

Piacentino V 3rd, Weber CR, Chen X, Weisser-Thomas J, Margulies KB, Bers DM et al (2003) Cellular basis of abnormal calcium transients of failing human ventricular myocytes. Circ Res 92:651–658

Baartscheer A, Schumacher CA, Belterman CN, Coronel R, Fiolet JW (2003) [Na+]i and the driving force of the Na+/Ca2+-exchanger in heart failure. Cardiovasc Res 57:986–995

Clusin WT (2003) Calcium and cardiac arrhythmias: DADs, EADs, and alternans. Crit Rev Clin Lab Sci 40:337–375

Gwathmey JK, Slawsky MT, Briggs GM, Morgan JP (1988) Role of intracellular sodium in the regulation of intracellular calcium and contractility. Effects of DPI 201-106 on excitation-contraction coupling in human ventricular myocardium. J Clin Invest 82:1592–1605

Fraser H, Belardinelli L, Wang L, Light PE, McVeigh JJ, Clanachan AS (2006) Ranolazine decreases diastolic calcium accumulation caused by ATX-II or ischemia in rat hearts. J Mol Cell Cardiol 41:1031–1038

Sossalla S, Wagner S, Rasenack EC, Ruff H, Weber SL, Schondube FA et al (2008) Ranolazine improves diastolic dysfunction in isolated myocardium from failing human hearts—role of late sodium current and intracellular ion accumulation. J Mol Cell Cardiol 14:14

Lindegger N, Hagen BM, Marks AR, Lederer WJ, Kass RS (2009) Diastolic transient inward current in long QT syndrome type 3 is caused by Ca2+ overload and inhibited by ranolazine. J Mol Cell Cardiol 47:326–334

Sabbah HN, Goldberg AD, Schoels W, Kono T, Webb C, Brachmann J et al (1992) Spontaneous and inducible ventricular arrhythmias in a canine model of chronic heart failure: relation to haemodynamics and sympathoadrenergic activation. Eur Heart J 13:1562–1572

Rao K, Fisher ML, Robinson S, Shorofsky S, Gottlieb SS (2007) Effect of chronic changes in heart rate on congestive heart failure. J Card Fail 13:269–274

Logeart D, Gueffet JP, Rouzet F, Pousset F, Chavelas C, Solal AC et al (2009) Heart rate per se impacts cardiac function in patients with systolic heart failure and pacing: a pilot study. Eur J Heart Fail 11:53–57

Antzelevitch C, Belardinelli L, Zygmunt AC, Burashnikov A, Di Diego JM, Fish JM et al (2004) Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties. Circulation 110:904–910

Maltsev VA, Sabbah HN, Undrovinas AI (2001) Late sodium current is a novel target for amiodarone: studies in failing human myocardium. J Mol Cell Cardiol 33:923–932

Nagatomo T, January CT, Makielski JC (2000) Preferential block of late sodium current in the LQT3 DeltaKPQ mutant by the class I(C) antiarrhythmic flecainide. Mol Pharmacol 57:101–107

Dumaine R, Wang Q, Keating MT, Hartmann HA, Schwartz PJ, Brown AM et al (1996) Multiple mechanisms of Na+ channel–linked long-QT syndrome. Circ Res 78:916–924

Winslow RL, Rice J, Jafri S, Marban E, O’Rourke B (1999) Mechanisms of altered excitation-contraction coupling in canine tachycardia-induced heart failure, II: model studies. Circ Res 84:571–586

Bers DM (2002) Cardiac excitation-contraction coupling. Nature 415:198–205

Kaab S, Nuss HB, Chiamvimonvat N, O’Rourke B, Pak PH, Kass DA et al (1996) Ionic mechanism of action potential prolongation in ventricular myocytes from dogs with pacing-induced heart failure. Circ Res 78:262–273

Harris DM, Mills GD, Chen X, Kubo H, Berretta RM, Votaw VS et al (2005) Alterations in early action potential repolarization causes localized failure of sarcoplasmic reticulum Ca2+ release. Circ Res 96:543–550

Wigle ED (1995) The failing heart. In: Diastolic dysfunction: pathology and treatment options. Lippincott-Raven, Philadelphia, pp 79–94

Pogwizd SM, Bers DM (2002) Na/Ca exchange in heart failure: contractile dysfunction and arrhythmogenesis. Ann N Y Acad Sci 976:454–465

Lakatta EG (1992) Functional implications of spontaneous sarcoplasmic reticulum Ca2+ release in the heart. Cardiovasc Res 26:193–214

Gwathmey JK, Copelas L, MacKinnon R, Schoen FJ, Feldman MD, Grossman W et al (1987) Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. Circ Res 61:70–76

Wilson LD, Wan X, Rosenbaum DS (2006) Cellular alternans: a mechanism linking calcium cycling proteins to cardiac arrhythmogenesis. Ann N Y Acad Sci 1080:216–234

Johnson N, Danilo P Jr, Wit AL, Rosen MR (1986) Characteristics of initiation and termination of catecholamine-induced triggered activity in atrial fibers of the coronary sinus. Circulation 74:1168–1179

Diaz ME, Trafford AW, O’Neill SC, Eisner DA (1997) Measurement of sarcoplasmic reticulum Ca2+ content and sarcolemmal Ca2+ fluxes in isolated rat ventricular myocytes during spontaneous Ca2+ release. J Physiol 501:3–16

Weisser-Thomas J, Piacentino V 3rd, Gaughan JP, Margulies K, Houser SR (2003) Calcium entry via Na/Ca exchange during the action potential directly contributes to contraction of failing human ventricular myocytes. Cardiovasc Res 57:974–985

Scirica BM, Morrow DA, Hod H, Murphy SA, Belardinelli L, Hedgepeth CM et al (2007) Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non ST-segment elevation acute coronary syndrome: results from the Metabolic Efficiency With Ranolazine for Less Ischemia in Non ST-Elevation Acute Coronary Syndrome Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) randomized controlled trial. Circulation 116:1647–1652

Black SC, Gralinski MR, McCormack JG, Driscoll EM, Lucchesi BR (1994) Effect of ranolazine on infarct size in a canine model of regional myocardial ischemia/reperfusion. J Cardiovasc Pharmacol 24:921–928

Gralinski MR, Black SC, Kilgore KS, Chou AY, McCormack JG, Lucchesi BR (1994) Cardioprotective effects of ranolazine (RS-43285) in the isolated perfused rabbit heart. Cardiovasc Res 28:1231–1237

Chandler MP, Stanley WC, Morita H, Suzuki G, Roth BA, Blackburn B et al (2002) Short-term treatment with ranolazine improves mechanical efficiency in dogs with chronic heart failure. Circ Res 91:278–280

Shah M, Akar FG, Tomaselli GF (2005) Molecular basis of arrhythmias. Circulation 112:2517–2529

Undrovinas AI, Maltsev VA, Higgins RSD, Silverman N, Goldstein S, Sabbah HN (2000) Amiodarone blocks the late sodium current in isolated ventricular myocytes of explanted failed human hearts. J Am Coll Cardiol 35:97A

Undrovinas A, Maltsev VA (2008) Late sodium current is a new therapeutic target to improve contractility and rhythm in failing heart. Cardiovasc Hematol Agents Med Chem 6:348–359

Undrovinas AI, Fleidervish IA, Makielski JC (1992) Inward sodium current at resting potentials in single cardiac myocytes induced by the ischemic metabolite lysophosphatidylcholine. Circ Res 71:1231–1241

Beresewicz A, Horackova M (1991) Alterations in electrical and contractile behavior of isolated cardiomyocytes by hydrogen peroxide: possible ionic mechanisms. J Mol Cell Cardiol 23:899–918

Song Y, Shryock JC, Wagner S, Maier LS, Belardinelli L (2006) Blocking late sodium current reduces hydrogen peroxide-induced arrhythmogenic activity and contractile dysfunction. J Pharmacol Exp Ther 318:214–222

Haigney MC, Lakatta EG, Stern MD, Silverman HS (1994) Sodium channel blockade reduces hypoxic sodium loading and sodium-dependent calcium loading. Circulation 90:391–399

Ver Donck L, Borgers M (1991) Myocardial protection by R 56865: a new principle based on prevention of ion channel pathology. Am J Physiol 261:H1828–H1835